Nurix Therapeutics (NRIX) News Today $17.50 -0.03 (-0.17%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$17.03 -0.47 (-2.71%) As of 05/22/2026 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRIX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Nurix Therapeutics, Inc. (NRIX) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptMay 22 at 7:01 PM | seekingalpha.comNurix Therapeutics' (NRIX) Buy Rating Reaffirmed at BTIG ResearchMay 18, 2026 | marketbeat.com7 Healthcare AI Stocks Under $50 With Huge Upside PotentialMay 18, 2026 | 247wallst.comHow Investors Are Reacting To Nurix Therapeutics (NRIX) Securing EHA Oral Slot For BTK Degrader DataMay 15, 2026 | uk.finance.yahoo.comNurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for ...May 15, 2026 | markets.businessinsider.comIs Nurix Therapeutics (NRIX) Stock’s Premium P/S Multiple Fair After Recent Mixed Share Price PerformanceMay 15, 2026 | finance.yahoo.comNurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual MeetingMay 14, 2026 | globenewswire.comVanguard Group Inc. Purchases 1,460,736 Shares of Nurix Therapeutics, Inc. $NRIXMay 13, 2026 | marketbeat.comNurix Therapeutics to Participate in Upcoming Investor ConferencesMay 13, 2026 | globenewswire.comNurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association CongressMay 12, 2026 | globenewswire.comA Nurix Therapeutics (NRIX) Insider Sold 5,394 Shares for $90,000May 6, 2026 | finance.yahoo.comHoute Hans Van Sells 14,055 Shares of Nurix Therapeutics (NASDAQ:NRIX) StockMay 5, 2026 | marketbeat.comHoute Hans Van Sells 2,388 Shares of Nurix Therapeutics (NASDAQ:NRIX) StockMay 1, 2026 | insidertrades.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMay 1, 2026 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 2,388 SharesApril 30, 2026 | marketbeat.comInsider Selling: Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 3,214 Shares of StockApril 30, 2026 | marketbeat.comPictet Asset Management Holding SA Acquires 1,487,060 Shares of Nurix Therapeutics, Inc. $NRIXApril 29, 2026 | marketbeat.comNurix Therapeutics Inc. (NRIX): Leadership in Targeted Protein Degradation Attracts Smart MoneyApril 27, 2026 | insidermonkey.comNurix Therapeutics (NASDAQ:NRIX) Receives Buy Rating from HC WainwrightApril 27, 2026 | marketbeat.comNeedham & Company LLC Reiterates Buy Rating for Nurix Therapeutics (NASDAQ:NRIX)April 23, 2026 | marketbeat.comNurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026April 22, 2026 | globenewswire.comWells Fargo Cuts PT on Nurix Therapeutics (NRIX) to $28 From $29April 19, 2026 | insidermonkey.comNurix Therapeutics, Inc. (NRIX) Presents at 25th Annual Needham Virtual Healthcare Conference TranscriptApril 17, 2026 | seekingalpha.comDid Sanofi Revenue Expiry and Rising R&D Spend Just Recast Nurix Therapeutics' (NRIX) Investment Narrative?April 11, 2026 | finance.yahoo.comNurix: 'Strong Buy' Bexobruditeg Development And Dual Degrader ZelebrudomideApril 9, 2026 | seekingalpha.comNurix Therapeutics shares edge higher despite Q1 earnings missApril 8, 2026 | msn.comNurix Advances NX-5948 Into Phase 3 Head-to-Head Battle in CLL/SLLApril 8, 2026 | tipranks.comNurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate UpdateApril 8, 2026 | globenewswire.comNurix Therapeutics to Participate in Upcoming Investor ConferenceApril 7, 2026 | globenewswire.comA Look At Nurix Therapeutics (NRIX) Valuation After Strong 1 Year Return And High Price To Sales RatioApril 4, 2026 | finance.yahoo.comNurix Therapeutics shows rising price performance with jump to 83 RS ratingMarch 26, 2026 | msn.comNurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 ...March 23, 2026 | markets.businessinsider.comNurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual MeetingMarch 23, 2026 | globenewswire.comNurix Therapeutics hits 80-plus relative strength rating benchmarkMarch 17, 2026 | msn.comNurix Therapeutics clears key benchmark, hitting 80-plus RS ratingMarch 13, 2026 | msn.comNurix Therapeutics (NRIX) Valuation Check After Recent Share Price Volatility And Rich Price To Sales MultipleFebruary 28, 2026 | finance.yahoo.comNurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 MillionFebruary 22, 2026 | fool.comNurix Therapeutics (NRIX) Is Down 7.4% After Wider 2025 Losses And New ESOP Share Shelf - What's ChangedFebruary 5, 2026 | finance.yahoo.comNurix Therapeutics, Inc. (NRIX): A bull case theoryFebruary 2, 2026 | msn.comNurix Therapeutics, Inc. (NRIX): A Bull Case Theory February 2, 2026 | insidermonkey.comStifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 CatalystsFebruary 2, 2026 | finance.yahoo.comInsider Selling: Nurix Therapeutics (NASDAQ:NRIX) CFO Sells 3,661 Shares of StockJanuary 31, 2026 | insidertrades.comHC Wainwright remains a buy on Nurix Therapeutics (NRIX)January 31, 2026 | msn.comNurix Therapeutics Exposed to Significant Foreign Exchange Risk Amid Unhedged Currency ExposureJanuary 30, 2026 | tipranks.comNurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate UpdateJanuary 28, 2026 | globenewswire.comAssessing Nurix Therapeutics (NRIX) Valuation After Recent Share Price VolatilityJanuary 25, 2026 | finance.yahoo.comNurix Therapeutics: Why This Company Could Double In Value?January 16, 2026 | seekingalpha.comNurix Therapeutics, Inc. (NRIX) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 13, 2026 | seekingalpha.comNurix Therapeutics, Inc. (NRIX) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 12, 2026 | seekingalpha.comNurix Therapeutics: Clinical Wins Offer Asymmetric UpsideJanuary 12, 2026 | seekingalpha.com Get Nurix Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRIX Media Mentions By Week NRIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRIX News Sentiment▼0.120.44▲Average Medical News Sentiment NRIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRIX Articles This Week▼44▲NRIX Articles Average Week Get the Latest News and Ratings for NRIX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SYRE News MIRM News RYTM News LNTH News TGTX News PTCT News SRRK News CNTA News CGON News BLTE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRIX) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
